3.70

6.02% 0.21

Pre-market: 3.53 -0.17 -4.59%

Briacell Therapeutics Corp (BCTX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Briacell Therapeutics Corp stock is traded at $3.70, with a volume of 338.58K. It is up +6.02% in the last 24 hours and up +19.74% over the past month. BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Previous Close:

$3.49

Open:

$3.51

24h Volume:

338.58K

Relative Volume:

1.65

Market Cap:

$32.19M

Revenue:

Net Income/Loss:

$-30.98M

P/E Ratio:

-0.303

EPS:

-12.2116

Net Cash Flow:

$-31.84M

1W Performance:

+6.63%

1M Performance:

+19.74%

6M Performance:

-49.18%

1Y Performance:

+27.15%

1-Day Range:

$3.4288

$3.82

1-Week Range:

$3.1104

$3.82

52-Week Range:

$0.61

$14.68

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name

Briacell Therapeutics Corp

Sector

Healthcare (1094)

Industry

Biotechnology (614)

Phone

(604) 921-1810

Address

3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER

Employee

Twitter

Next Earnings Date

2026-06-15

Latest SEC Filings

BCTX's Discussions on Twitter

Compare BCTX vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BCTX Briacell Therapeutics Corp	3.70	32.19M	0	-30.98M	-31.84M	-12.21
VRTX Vertex Pharmaceuticals Inc	498.43	126.50B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	662.88	69.50B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	915.30	56.92B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	323.50	43.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.77	40.34B	742.00K	-1.37B	-1.07B	-7.0731

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-14-22	Initiated	H.C. Wainwright	Buy

Briacell Therapeutics Corp Stock (BCTX) Latest News

Jul 08, 2026

Why Briacell Therapeutics Corp stock is skyrocketing today - Wealth Awesome

Jul 08, 2026

Jul 07, 2026

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT - Investing News Network

Jul 07, 2026

BriaCell engages consultants for Bria-IMT commercialization planning - Investing.com

Jul 07, 2026

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™ - The Manila Times

Jul 07, 2026

BriaCell engages consultants for Bria-IMT commercialization planning By Investing.com - Investing.com UK

Jul 07, 2026

BriaCell taps CRA and Kaleio for Bria-IMT launch planning - Stock Titan

Jul 07, 2026

Jun 30, 2026

Why did BCTX stock surge 50% today? - MSN

Jun 30, 2026

Jun 29, 2026

Number of shareholders of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView

Jun 29, 2026

Price to book forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView

Jun 29, 2026

Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView

Jun 29, 2026

Jun 28, 2026

Enterprise value to EBIT forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView

Jun 28, 2026

Jun 27, 2026

Price to earnings forward of BriaCell Therapeutics Corp – TSX:BCT - TradingView

Jun 27, 2026

Price to sales forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView

Jun 27, 2026

Price to earnings forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView

Jun 27, 2026

Enterprise value to EBIT forward of BriaCell Therapeutics Corp – TSX:BCT - TradingView

Jun 27, 2026

Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView

Jun 27, 2026

Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView

Jun 27, 2026

Enterprise value to EBITDA forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView

Jun 27, 2026

Jun 26, 2026

BriaCell Subsidiary Highlights Interim Results, Ongoing Losses - TipRanks

Jun 26, 2026

BriaCell subsidiary BriaPro reports $1.32M assets, $299,950 cash after sCD80 license acquisition - TradingView

Jun 26, 2026

BriaCell (NASDAQ: BCTX) unit BriaPro posts loss and acquires sCD80 license - Stock Titan

Jun 26, 2026

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT - marketscreener.com

Jun 25, 2026

BriaCell (BCTX) Partners with Uneedle for Microneedle Technology Development - GuruFocus

Jun 25, 2026

BriaCell plans microneedle delivery scale-up for breast cancer drug - Stock Titan

Jun 25, 2026

Jun 24, 2026

Beyond the Syringe: How Microneedles Could Redefine Cancer Care - BriefGlance

Jun 24, 2026

Jun 23, 2026